Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis.
Adult
Asian People
Autoantibodies
/ immunology
Diagnosis, Differential
Encephalomyelitis
/ diagnostic imaging
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Sclerosis
/ diagnostic imaging
Myelin-Oligodendrocyte Glycoprotein
/ immunology
Neuroimaging
/ methods
Neuromyelitis Optica
/ diagnostic imaging
Sensitivity and Specificity
MRI
Multiple sclerosis
brain
neuromyelitis optica spectrum disorder
Journal
Multiple sclerosis (Houndmills, Basingstoke, England)
ISSN: 1477-0970
Titre abrégé: Mult Scler
Pays: England
ID NLM: 9509185
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
pubmed:
8
3
2018
medline:
10
1
2020
entrez:
8
3
2018
Statut:
ppublish
Résumé
We aimed to evaluate the utility of the recently described brain lesion distribution criteria to differentiate multiple sclerosis (MS) from aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein immunoglobulin G-associated encephalomyelitis (MOG-EM) at disease onset in an Asian cohort. A total of 214 patients who fulfilled the published criteria for MS, NMOSD, or MOG-EM and underwent brain magnetic resonance imaging (MRI) within 3 months of disease onset were enrolled. The brain lesion distribution criteria were defined as the presence of a lesion adjacent to the body of the lateral ventricle and in the inferior temporal lobe, or an S-shaped U-fiber lesion, or a Dawson's finger-type lesion. Brain lesions were identified in the initial MRI scans of 166/214 patients. The distribution criteria were applied to these scans (MS ( n = 94), NMOSD ( n = 64), and MOG-EM ( n = 8)). The sensitivity, specificity, and positive and negative predictive values of the criteria for MS versus NMOSD were 79.8%, 87.5%, 90.4%, and 74.7%, and for MS versus MOG-EM these were 79.8%, 100%, 100%, and 29.6%, respectively. These findings suggest that the brain lesion distribution criteria are helpful in distinguishing MS from NMOSD and MOG-EM in an Asian population, even at disease onset.
Identifiants
pubmed: 29512413
doi: 10.1177/1352458518761186
pmc: PMC6425520
doi:
Substances chimiques
Autoantibodies
0
MOG protein, human
0
Myelin-Oligodendrocyte Glycoprotein
0
Types de publication
Evaluation Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
585-590Références
Mult Scler. 2014 May;20(6):695-704
pubmed: 24072726
J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):132-136
pubmed: 27951522
Neurology. 2013 Apr 2;80(14):1330-7
pubmed: 23486868
Lancet Neurol. 2016 Mar;15(3):292-303
pubmed: 26822746
Curr Opin Neurol. 2015 Jun;28(3):193-205
pubmed: 25887774
Nat Rev Neurol. 2010 Jul;6(7):383-92
pubmed: 20639914
Neurology. 2015 Mar 17;84(11):1165-73
pubmed: 25695963
J Clin Neurol. 2017 Apr;13(2):175-180
pubmed: 28271642
Neurology. 2015 Jul 14;85(2):177-89
pubmed: 26092914
Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(3):e89
pubmed: 25821844
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Neurology. 2013 Nov 26;81(22):1966
pubmed: 24276335